People · Operator
Named in public records as an officer, director or promoter · active 2015–2023 · Pharmaceuticals, Biotech / Pharma, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| LP Investors, LLC | — | Pharmaceuticals | Series B | $40.0M | $1.4B | 2017 |
| NJ BIO, Inc. | — | Biotech / Pharma | Series A | $5.6M | $55.0M | 2023 |
| LeanOnWe, Inc | — | Other Health Care | Pre-Seed | $925K | $28.5M | 2015 |
RONALD GOLD at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside RONALD GOLD on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Nikhil Puri | 1 | 2 |
| STEVEN KLOSK | 1 | 1 |
| ANJANISH GONDALIA | 1 | 1 |
| PRIYASHRI NAYAK | 1 | 1 |
| CHETAN JAIN | 1 | 1 |
| NARESHKUMAR JAIN | 1 | 1 |
| Betsy C Gold | 1 | 1 |
| Rasik Gondalia | 1 | 1 |
| Steven M. Goldman | 1 | 1 |
| David M. Seltzer | 1 | 1 |
| Christopher Semple | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.